Compare AORT & POET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AORT | POET |
|---|---|---|
| Founded | 1984 | 1972 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | 1996 | 2008 |
| Metric | AORT | POET |
|---|---|---|
| Price | $25.18 | $10.83 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $49.40 | N/A |
| AVG Volume (30 Days) | 284.3K | ★ 42.6M |
| Earning Date | 05-07-2026 | 08-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 165.62 | N/A |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $298,836,000.00 | N/A |
| Revenue This Year | $14.20 | $848.96 |
| Revenue Next Year | $11.20 | $700.00 |
| P/E Ratio | $169.71 | ★ N/A |
| Revenue Growth | ★ 18.01 | N/A |
| 52 Week Low | $28.07 | $3.87 |
| 52 Week High | $48.25 | $15.50 |
| Indicator | AORT | POET |
|---|---|---|
| Relative Strength Index (RSI) | 22.92 | 59.79 |
| Support Level | N/A | $5.47 |
| Resistance Level | $38.43 | $15.50 |
| Average True Range (ATR) | 2.08 | 1.69 |
| MACD | -0.80 | 0.07 |
| Stochastic Oscillator | 29.80 | 50.60 |
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.